2007
DOI: 10.1016/j.tox.2006.11.018
|View full text |Cite
|
Sign up to set email alerts
|

Challenging the regulatory requirement for conventional acute toxicity studies in pharmaceutical drug development

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
4
0

Year Published

2015
2015
2018
2018

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(4 citation statements)
references
References 0 publications
0
4
0
Order By: Relevance
“…Objective of acute toxicity tests is to detect a dose producing major adverse effects and an assessment of the minimum dose causing lethality. 6 Calotropis gigantean (Linn.) R. Br.…”
Section: Introductionmentioning
confidence: 99%
“…Objective of acute toxicity tests is to detect a dose producing major adverse effects and an assessment of the minimum dose causing lethality. 6 Calotropis gigantean (Linn.) R. Br.…”
Section: Introductionmentioning
confidence: 99%
“…So it is significant to determine the safety of these remedies in order to support their use. Acute toxicity is an initial screening step, mandatory in the toxic assessment and evaluation of all biological compounds (Akhila et al, 2007) and it establishes the moderate lethal dose (LD 50 ) of biological compounds (Robinson et al, 2007). Acute toxicity is usually defined as the variations occurring instantly or a short time following a single administration of compound within 24 hrs (OECD, 2000).…”
Section: Discussion:-mentioning
confidence: 99%
“…Determination of acute oral toxicity is usually an initial screening step in the assessment and evaluation of the toxic characteristics of all compounds [9]. The present study focuses on the acute toxicity studies, which identify a dose causing major adverse effects and an estimation of the minimum dose causing lethality [10].…”
Section: Introductionmentioning
confidence: 99%